ACS | Jotup

Revvity Signals Software Introduces Signals ChemDraw Offering to Set New Standard for Cloud-Native Chemistry Communication

Retrieved on:

Monday, March 18, 2024

Today, Revvity, Inc. (NYSE: RVTY) announced that its software and informatics division, Revvity Signals Software , is introducing the new Signals ChemDraw® offering, the latest advancement in the Revvity Signals Software portfolio.

Key Points:

Today, Revvity, Inc. (NYSE: RVTY) announced that its software and informatics division, Revvity Signals Software , is introducing the new Signals ChemDraw® offering, the latest advancement in the Revvity Signals Software portfolio.
"By integrating this premier chemistry communication tool into our cloud native Revvity Signals Research platform, we're setting the stage for a significant leap in productivity.
By transitioning from its ChemOffice and ChemOffice+ Cloud Standard to its Signals ChemDraw platform, Revvity Signals Software is providing customers a unified, cohesive interface designed for enhancing scientific research efficiency and focus.
Revvity Signals Software will present its Signals ChemDraw solution at ACS Spring 2024 (Booth #2842), March 17-21, in New Orleans, Louisiana.

Tango Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Highlights

Retrieved on:

Monday, March 18, 2024

Tango Therapeutics, Inc. (NASDAQ: TNGX), a clinical-stage biotechnology company committed to discovering and delivering the next generation of precision cancer medicines, reported its financial results for the fourth quarter and full year ended December 31, 2023, and provided business highlights.

Key Points:

Tango Therapeutics, Inc. (NASDAQ: TNGX), a clinical-stage biotechnology company committed to discovering and delivering the next generation of precision cancer medicines, reported its financial results for the fourth quarter and full year ended December 31, 2023, and provided business highlights.
“In 2023, we made meaningful progress developing precision oncology treatments and now have four ongoing phase 1/2 clinical trials.
The U.S. Food and Drug Administration (FDA) granted Orphan Drug Designation (ODD) to TNG462 in December 2023 for the treatment of soft tissue sarcomas.
The increase is the result of out-licensing a program to Gilead for $5.0 million during the second quarter of 2023.

Europe HVAC Market Outlook & Forecast Report 2024-2029: EU and Government Incentives Such as REPowerEU Fueling Expansion - ResearchAndMarkets.com

Retrieved on:

Monday, March 11, 2024

The "Europe HVAC Market - Industry Outlook & Forecast 2024-2029" report has been added to ResearchAndMarkets.com's offering.

Key Points:

The "Europe HVAC Market - Industry Outlook & Forecast 2024-2029" report has been added to ResearchAndMarkets.com's offering.
Aldes, Daikin, Johnson Controls, Mitsubishi Electric, Ostberg, Pentair, Robert Bosch, Rheem Manufacturing Company, Samsung, Siemens AG, Systemair, and Zehnder are the key players in the Europe HVAC market.
Hence, although sustainability is a significant factor in the HVAC industry, incorporating technology and statutory standards is a step ahead in the competitive market.
The Western European region held the most significant Europe HVAC market share, valued at over USD 36 billion in 2023.

Alcatraz AI Unveils Rock X: Revolutionizing Exterior Access Control with Frictionless and Secure Facial Authentication Technology

Retrieved on:

Tuesday, March 26, 2024

PBX, Temperature, IP66, Organization, Face, Darkness, AI, Lido, Control, Access control, ISC, Tymnet, Completeness, Sunlight, ACS, Rain, SIP, Privacy, Snow, Frictionless, Weather

CUPERTINO, Calif., March 26, 2024 /PRNewswire-PRWeb/ -- Alcatraz AI, a global leader in frictionless access control solutions, is proud to announce the debut of the revolutionary exterior Rock X during ISC West 2024 in Las Vegas, showcased in Booth 31075.

Key Points:

Alcatraz AI Unveils Rock X: Revolutionizing Exterior Access Control with Frictionless and Secure Facial Authentication Technology
CUPERTINO, Calif., March 26, 2024 /PRNewswire-PRWeb/ -- Alcatraz AI, a global leader in frictionless access control solutions, is proud to announce the debut of the revolutionary exterior Rock X during ISC West 2024 in Las Vegas, showcased in Booth 31075.
Rock X sets a new standard in outdoor access control, featuring frictionless and secure facial authentication technology for a wide range of applications.
"The introduction of the exterior Rock X marks a paradigm shift in outdoor access control," said Tina D'Agostin, CEO at Alcatraz AI.
Yet, Alcatraz has successfully overcome these challenges with Rock X, making facial authentication universal.

PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition

Retrieved on:

Tuesday, March 26, 2024

Solvent, CDMO, American Chemical Society, Biocatalysis, PMI, Carbon footprint, Decarboxylation, Hydrogenation, Green Chemistry Award, Chemistry, Amination, Safety, ACS, GCI, Fine chemical

This esteemed award, marking the company's second consecutive win among global CDMO companies, is a testament to PharmaBlock's persistent commitment to green chemistry and its unwavering efforts in crafting innovative, sustainable solutions for the pharmaceutical industry.

Key Points:

This esteemed award, marking the company's second consecutive win among global CDMO companies, is a testament to PharmaBlock's persistent commitment to green chemistry and its unwavering efforts in crafting innovative, sustainable solutions for the pharmaceutical industry.
These compounds are vital in the pharmaceutical industry and serve as raw materials or key intermediates for many marketed drugs.
PharmaBlock has been developing a comprehensive suite of solutions, featuring flow chemistry, micropacked bed hydrogenation, biocatalysis, immobilized catalysis, etc.
"We are thrilled to receive the CMO Excellence in Green Chemistry Award for the second consecutive year.

CAS Announces 2024 Selections for Prestigious CAS Future Leaders™ Program

Retrieved on:

Monday, March 25, 2024

Chemical Society, IIT Indore, Science, Harvard University, Polymer, Research, United States Army, CAS, United States Military Academy, ACS, Army, Management

COLUMBUS, Ohio, March 25, 2024 /PRNewswire/ -- CAS, a division of the American Chemical Society specializing in scientific knowledge management, is proud to announce the 2024 CAS Future Leaders. These exceptional early-career scientists were selected from a large pool of global candidates who applied for a spot in the program known as one of the best leadership learning experiences in the world of science.

Key Points:

COLUMBUS, Ohio, March 25, 2024 /PRNewswire/ -- CAS, a division of the American Chemical Society specializing in scientific knowledge management, is proud to announce the 2024 CAS Future Leaders .
Participants in the program, which will take place in August, will also get a behind-the-scenes look into how CAS connects the world's science.
They will present their research at ACS Fall 2024 in Denver, Colorado, and receive a three-year ACS membership as well.
"I am thrilled to be selected for the 2024 CAS Future Leaders program alongside such an esteemed group of interdisciplinary scientists.

CAS Announces 2024 Selections for Prestigious CAS Future Leaders™ Program

Retrieved on:

Monday, March 25, 2024

Chemical Society, IIT Indore, Science, Harvard University, Polymer, Research, United States Army, CAS, United States Military Academy, ACS, Army, Management

COLUMBUS, Ohio, March 25, 2024 /PRNewswire/ -- CAS, a division of the American Chemical Society specializing in scientific knowledge management, is proud to announce the 2024 CAS Future Leaders. These exceptional early-career scientists were selected from a large pool of global candidates who applied for a spot in the program known as one of the best leadership learning experiences in the world of science.

Key Points:

COLUMBUS, Ohio, March 25, 2024 /PRNewswire/ -- CAS, a division of the American Chemical Society specializing in scientific knowledge management, is proud to announce the 2024 CAS Future Leaders .
Participants in the program, which will take place in August, will also get a behind-the-scenes look into how CAS connects the world's science.
They will present their research at ACS Fall 2024 in Denver, Colorado, and receive a three-year ACS membership as well.
"I am thrilled to be selected for the 2024 CAS Future Leaders program alongside such an esteemed group of interdisciplinary scientists.

Weekly Recap: 13 Press Releases You Might Have Missed

Retrieved on:

Friday, March 22, 2024

NEW YORK, March 22, 2024 /PRNewswire/ -- With thousands of press releases published each week, it can be difficult to keep up with everything on PR Newswire. To help journalists and consumers stay on top of the week's most newsworthy and popular releases, here's a recap of some major stories from the week that shouldn't be missed.

Key Points:

The chargers will be integrated with the bp pulse app, allowing users to locate the site, access real-time charging availability, and connect to WiFi.
These are just a few of the recent press releases that consumers and the media should know about.
To be notified of releases relevant to their coverage area, journalists can set up a custom newsfeed with PR Newswire for Journalists .
Related Resources: Our journalist- and blogger-focused blog, Beyond Bylines , features regular media news roundups, writing tips, upcoming events, and more.

Dr. Jason D. Fraser Appointed Division Chief of Pediatric Surgery at Phoenix Children's

Retrieved on:

Thursday, March 21, 2024

Editorial, Certification, Kansas City University, Mayo Clinic Arizona, Phoenix Children's Hospital, Patient, Mayo Clinic, Trauma, University, MD, American College, General surgery, Hospital, ACS, Mercy, Bariatric surgery, Dentistry

PHOENIX, March 21, 2024 /PRNewswire/ -- Phoenix Children's today announced Jason D. Fraser, MD, will join the rapidly growing health system as division chief of pediatric surgery beginning in April.

Key Points:

PHOENIX, March 21, 2024 /PRNewswire/ -- Phoenix Children's today announced Jason D. Fraser, MD, will join the rapidly growing health system as division chief of pediatric surgery beginning in April.
Phoenix Children's is verified by the American College of Surgeons (ACS) as the only Level 1 Children's Surgery Center in Arizona.
As division chief of pediatric surgery, Dr. Fraser will provide strategic direction and administrative leadership for neonatal, pediatric and trauma surgery throughout Phoenix Children's health system, which will include three hospital campuses and three ambulatory surgery centers by the end of 2024.
Dr. Fraser joins Phoenix Children's from Children's Mercy in Kansas City, Missouri, where he served as medical director of the Opioid Stewardship Program, director of the Pediatric Surgery Fellowship Program, director of Bariatric Surgery and director of General Surgery Residents.

Manager of Cancer Care Equity Program for NCCN Named to '40 Under 40' List from National Minority Quality Forum

Retrieved on:

Wednesday, March 20, 2024

Health, Bias, HERC, NCCN, Cancer, Life, MPA, Health equity, ACS, ACCE, Legislation, DEI, Nursing

PLYMOUTH MEETING, Pa., March 20, 2024 /PRNewswire/ -- The National Comprehensive Cancer Network® (NCCN®)—an alliance of leading cancer centers—is pleased to announce that Taneal D. Carter, MS, MPA, has been named one of 2024's '40 Under 40' by the National Minority Quality Forum (NMQF). Every year, NMQF selects 40 health leaders from minoritized populations under the age of 40 who have been leading the charge to better patient outcomes and build sustainable healthy communities. These 40 leaders have persevered in strengthening their communities and reducing health disparities amid ongoing challenges within the healthcare system. Carter will receive her award at the NMQF Leadership Summit on Health Disparities and Health Braintrust during National Minority Health Month in April.

Key Points:

Taneal Carter oversees numerous projects and programs to reduce disparities in cancer care, including the Health Equity Report Card, the Alliance for Cancer Care Equity, and the NCCN Diversity, Equity, and Inclusion Directors Forum.
Carter has served as manager of NCCN's Cancer Care Equity Program since 2022.
Additionally, Carter contributes to numerous panels, summits, and white papers on the topic of improving equity in cancer care.
Visit NCCN.org/equity to learn more about NCCN's ongoing efforts to improve equitable cancer care under Taneal's leadership.